Answers are grounded in this paper and cite their sources.
This commentary analyzes the implications of the US National Action Plan for clinical management and antibiotic prescribing, highlighting ethical considerations.
The United States National Action Plan for Combating Antibiotic-Resistant Bacteria provides strategic direction within the nation's interagency to mitigate antibiotic resistance. This commentary provides an ethics-informed analysis of this document’s implications for clinical management of infectious diseases and antibiotic prescribing.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: